Manifold Bio, a Boston-based platform therapeutics company, announced a strategic collaboration and license agreement with Roche to develop several next-generation blood-brain barrier (BBB) shuttles intended …
Read More
Rare diseases sit at an uncomfortable scale: about 30 million people in the U.S., roughly >300 million worldwide. According to NIH, there are an estimated …
Read More
Flatiron Health has launched six new hematology datasets built using AI and large language models (LLMs), unlocking longitudinal clinical data for 505,000 patients with blood …
Read More
Recursion announces the acceptance of its whole-genome Microglia Map by Roche and Genentech, marking the culmination of a three-year collaboration focused on decoding microglial cell …
Read More
Genesis Molecular AI, in collaboration with NVIDIA, has announced a generative 3D foundation model for protein–ligand structure prediction, Pearl (Placing Every Atom in the Right …
Read More
Flagship Pioneering announced Expedition Medicines after three years of internal development, committing $50 million to scale a quantum-chemistry-driven generative platform for covalent small-molecule discovery, with …
Read More
